MoneyWorks4Me

Medico Remedies informs about board meeting

12 May 2022 Evaluate
Medico Remedies has informed that the meeting of the Board of Directors of the Company is scheduled on 20/05/2022, to consider and approve, Audited Financial Results for the half year ended 31st March, 2022 and Audited Financial Statements for the year ended on 31st March, 2022; and Any other business with the permission of the Chair.

The above information is a part of company’s filings submitted to BSE.

Medico Remedies Share Price

42.48 -0.26 (-0.61%)
19-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1898.00
Dr. Reddys Labs. 1171.00
Cipla 1416.00
Lupin 2220.00
Zydus Lifesciences 1105.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: